During the past decade, Cardiology Consultants of Philadelphia conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology Consultants of Philadelphia" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Amryt Pharma" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Consultants of Philadelphia" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Consultants of Philadelphia" are "Atrial Fibrillation" (5 trials), "Heart Failure" (5 trials), "Coronary Artery Disease" (3 trials), "Myocardial Infarction" (3 trials) and "Atherosclerosis" (2 trials). Many other conditions were trialed in "Cardiology Consultants of Philadelphia" in a lesser frequency.

Most popular intervention types in "Cardiology Consultants of Philadelphia" are "Drug" (13 trials), "Device" (9 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Simvastatin" (2 trials), "Acetylsalicylic acid" (1 trials), "Adenosine SPECT myocardial perfusion imaging" (1 trials) and "BiV/MPP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Consultants of Philadelphia" are 24 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiology Consultants of Philadelphia". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Cardiology Consultants of Philadelphia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Consultants of Philadelphia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".

Cardiology Consultants of Philadelphia has several departments that took part in Clinical trials: "Cardiology Consultants of Philadelphia Yardley" - 3 trials